LOUISVILLE, Colo., June 18, 2020 /PRNewswire/ -- Trio Health, a leading technology provider of real-world data and insights on patients announces the launch of the Rheumatology Webinar Series with the first live webinar scheduled for June 26, 2020, 12:00 pm eastern time: "Real World Data Insights on the Impact of the COVID-19 Pandemic in Real-World Rheumatology Patients - Case Studies of Real Patients who have RA and were exposed to COVID-19."
This webinar series will continue to explore how advanced, real-world evidence generation methodologies and their application in rheumatologic disease research can enable biopharmaceutical companies to provide unprecedented data on patients including real time data to drive better product value and commercialization strategies which can in turn improve overall patient outcomes and payer access.
Last year, Trio Health announced an exclusive partnership with American Rheumatology Network (ARN) to create the nation's first comprehensive rheumatology registry with full access to patients' medical records and chart notes along with pharmacy dispensing data that is refreshed, verified, and available nightly. Today, the database includes over 100,000 patients and links clinical data, infusion, patient-reported outcomes, and pharmacy information to create a premier, high-quality and interactive data source using an agile proprietary multi-disease platform, MDX. Trio Health's MDX platform and its unique approach focuses on processing, curating, and linking real-world datasets to deliver research rich and regulatory-grade data that is 100 percent verified and cross-validated using medical scribes.
"The new webinar series offers our clients a one-of-a-kind view into insights that are relevant and reliable with patient experiences and outcomes at the point of care in a scientific way, outside of traditional clinical trials," said Trio Health COO, Ramita Tandon. "The ability for this Registry Network to take clinical evidence directly from large community-based practices linked to specialty pharmacy dispensing data is a totally unique, market-defining product that can help clients for example, who may be looking to seek approval to expand label for an existing treatment or create evidence-based pathways. We want to offer our audience an opportunity to hear first-hand how these insights can help re-define how real-world data is applied to treat rheumatologic diseases."
The Trio-Health and ARN Registry is unique among rheumatology registries in capturing real-time, patient level data to not only capture insights to support real-world studies, pharmacovigilance, registries, and clinical trials but to truly understand overall drug performance with a deep dive in line of therapies (LOTs) and why patients switch and discontinue LOTs, to create strong pathways to improve payer access and market share.
The webinar series will include ARN clinical physicians along with industry experts to discuss the current market trends in utilization of RA drugs, impact of care during COVID-19, persistency and adherence, JAK utilization, biosimilar uptake, and other topics based on the current insights taking place within the ARN community-based network.
About Trio Health Trio Health's mission is to improve the quality of care in patient outcomes through coordinating the efforts of all patient care stakeholders. Their first-of-its-kind Multi-Disease Platform (MDX) tracks patients throughout the course of their treatment, giving biopharmaceutical companies, specialty pharmacies, and physicians access to information and opportunities that simply doesn't exist anywhere else. Learn more at www.triohealth.com.